[Breast cancer prognosis in Salah Azaiez Institute of Cancer, Tunis].
We estimated survival rate at 9 years of all (470) women with breast cancer diagnosed at Salah Azaïez Institute of Cancer in Tunis to identify the main prognosis factors. Data were collected on residence, socioeconomic level, circumstances of discovery of the tumour, histological type, tumour size, presence of metastases, extension of the tumour, treatment and survival. Comparison of survival curves was done with Log Rank test. Cox model was used for multivariate adjustments and calculation of the hazard ratio (HR) (relative risk of death). There was a survival rate of 61% at 5 years and of 51% at 9 years. Tumour size >5 cm was significantly associated with lower survival as was capsular rupture. After stratification for tumour size and age, only surgery and radiotherapy were significantly associated with improved survival.
Ben Gobrane
H
H
Institut national de la Santé publique, Tunis, Tunisie.
Fakhfakh
R
R
Rahal
K
K
Ben Ayed
F
F
Mâalej
M
M
Ben Abdallah
M
M
Achour
N
N
Hsairi
M
M
D000328:Adult; D017677:Age Distribution; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D002173:Cancer Care Facilities; D005260:Female; D006801:Humans; D015994:Incidence; D008408:Mastectomy; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011159:Population Surveillance; D011379:Prognosis; D016016:Proportional Hazards Models; D011878:Radiotherapy; D012111:Residence Characteristics; D012307:Risk Factors; D012423:Rural Health / Q000706:statistics & numerical data; D012959:Socioeconomic Factors; D015996:Survival Rate; D016896:Treatment Outcome; D014416:Tunisia / Q000453:epidemiology; D014504:Urban Health / Q000706:statistics & numerical data
D000970:Antineoplastic Agents